Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases
Dipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these patients, according to research presented this week at ...
Oct 30, 2013
0
0